Atorvastatin Calcium Tablets Recalled for Presence of Foreign Substance

November 28, 2012

On November 9, 2012, Ranbaxy Inc. issued a voluntary recall of 41 affected lots of Atorvastatin Calcium Tablets (10 mg, 20 mg and 40 mg) at the retail level. The affected lots may contain very small glass particles resembling fine grains of sand (less than 1 mm in size). Because the size of the glass particles which may be present in the affected lots are so small, the risk of a significant safety concern is minimal. However, it is possible that patients taking an affected tablet could have an adverse reaction due to physical irritation.

Atorvastatin Calcium Tablets are used to lower blood cholesterol. The medication is packaged in plastic bottles, in quantities of 90 and 500 tablets per bottle. The affected lots of Atorvastatin Calcium Tablets and their respective NDC code, expiration date information can be found in Ranbaxy's press release. The recall does not include the 80 mg dosage strength of Atorvastatin Calcium Tablets.

You should immediately contact your physician or health care provider if you have experienced any problems that may be related to taking or using this medication.

For more information, please read the MedWatch safety alert.